<p>India's drugs regulator is likely to approve administering two doses of the <a href="https://www.deccanherald.com/national/india-approves-astrazeneca-coronavirus-vaccine-countrys-first-934359.html" target="_blank">AstraZeneca</a>/Oxford vaccine and another <a href="https://www.deccanherald.com/national/cdsco-panel-approves-bharat-biotechs-covaxin-for-emergency-use-934456.html" target="_blank">locally-developed one</a> by Bharat Biotech, each four weeks apart, two sources with knowledge of the matter told Reuters on Saturday.</p>.<p>Experts at India's Central Drugs Standards Control Organisation (CDSCO) have already approved the vaccines and a final decision is expected to be announced by the agency's chief at a news conference scheduled on Sunday.</p>.<p>Calls to CDSCO were unanswered outside regular business hours.</p>
<p>India's drugs regulator is likely to approve administering two doses of the <a href="https://www.deccanherald.com/national/india-approves-astrazeneca-coronavirus-vaccine-countrys-first-934359.html" target="_blank">AstraZeneca</a>/Oxford vaccine and another <a href="https://www.deccanherald.com/national/cdsco-panel-approves-bharat-biotechs-covaxin-for-emergency-use-934456.html" target="_blank">locally-developed one</a> by Bharat Biotech, each four weeks apart, two sources with knowledge of the matter told Reuters on Saturday.</p>.<p>Experts at India's Central Drugs Standards Control Organisation (CDSCO) have already approved the vaccines and a final decision is expected to be announced by the agency's chief at a news conference scheduled on Sunday.</p>.<p>Calls to CDSCO were unanswered outside regular business hours.</p>